Log In
BCIQ
Print this Print this
 

Timoptic, timolol

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionAdrenergic receptor beta (ADRB) blocker
Molecular Target Adrenergic receptor beta (ADRB)
Mechanism of ActionAdrenergic receptor beta (ADRB) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$700.0M

$600.0M

$100.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today